The addition of a biomanufacturing plant in Florida will support the high demand for Akron Biotech’s cytokine and media products from the blossoming cell and gene therapy sector. Akron Biotech has expanded its operations by acquiring a biologics facility in Sarasota, Florida second manufacturing plant. The firm makes cGMP-compliant cytokines that are embedded in numerous clinical and commercial cell therapies and the addition of a second facility is needed to expand capacity to meet the tremendous demand, according to Akron…
